These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22385508)

  • 21. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.
    Balakrishnan A; Vyas A; Deshpande K; Vyas D
    World J Gastroenterol; 2016 Feb; 22(7):2159-64. PubMed ID: 26900281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy for advanced colorectal cancer].
    Munakata M; Sakata Y
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():30-6. PubMed ID: 22213927
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the PI3K pathway in colorectal cancer.
    Papadatos-Pastos D; Rabbie R; Ross P; Sarker D
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):18-30. PubMed ID: 25591826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin, the new targeted therapy in colorectal cancer.
    Fuchs CS
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):186-9. PubMed ID: 24927268
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug development: Mix and match.
    Scudellari M
    Nature; 2015 May; 521(7551):S12-4. PubMed ID: 25970452
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reception and adjuvant chemotherapy for metastatic site of colorectal cancer].
    Nakamura M
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1381-6. PubMed ID: 25577807
    [No Abstract]   [Full Text] [Related]  

  • 28. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and clinical profiles of panitumumab injection (Vectibix®)].
    Matsudaira T; Asahi D; Yana I; Aboshi M
    Nihon Yakurigaku Zasshi; 2011 Jan; 137(1):31-41. PubMed ID: 21233587
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting FGF receptors in colorectal cancer: from bench side to bed side.
    Abdel-Rahman O
    Future Oncol; 2015; 11(9):1373-9. PubMed ID: 25952783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Targeted therapies in digestive oncology].
    Amram ML; Benamran DA; Roth AD
    Rev Med Suisse; 2011 May; 7(296):1131-2, 1134-6. PubMed ID: 21721202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of Gene Mutations in Colorectal Cancer: Implications for Treatment.
    Dienstmann R; Tabernero J
    Cancer J; 2016; 22(3):149-55. PubMed ID: 27341591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Colorectal Cancer Stem Cell.
    Medema JP
    N Engl J Med; 2017 Aug; 377(9):888-890. PubMed ID: 28854096
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis and colorectal cancer.
    Watson AJ
    Gut; 2004 Nov; 53(11):1701-9. PubMed ID: 15479695
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutation of EGFR signaling pathway and therapy for metastatic colorectal cancer].
    Nozawa K; Watanabe T
    Gan To Kagaku Ryoho; 2010 May; 37(5):791-4. PubMed ID: 20495308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could JAG1 protein inhibition prevent colorectal cancer?
    López-Arribillaga E; Rodilla V; Espinosa L
    Future Oncol; 2019 Feb; 15(4):345-347. PubMed ID: 30620224
    [No Abstract]   [Full Text] [Related]  

  • 40. Colorectal cancer in 2012: Revisiting landmark trials and identifying new therapies.
    Wu C; Goldberg RM
    Nat Rev Clin Oncol; 2013 Feb; 10(2):71-2. PubMed ID: 23296108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.